Related Experiment Videos
Comparison between one and three years of treatment in uncomplicated childhood epilepsy: a prospective study. I.
G Braathen1, T Andersson, H Gylje
1Department of Pediatrics, Karolinska Institute, Huddinge University Hospital, Sweden.
Insights
Three years of epilepsy treatment in children yielded higher remission rates than one year. However, treatment duration is only critical for complex partial seizures, not benign or simple partial types.
Area of Science:
- Pediatric Neurology
- Epileptology
Background:
- Idiopathic epilepsy affects children, with treatment duration a key factor in remission.
- Understanding optimal treatment length is crucial for managing pediatric epilepsy.
Purpose of the Study:
- To compare the efficacy of 1-year versus 3-year epilepsy treatment durations in children.
- To determine if a 1-year treatment course is as effective as a 3-year course for achieving remission in pediatric idiopathic epilepsy.
Main Methods:
- A prospective randomized study involving 207 children (aged 2-16 years) with epileptic seizures.
- Participants were assigned to either 1 or 3 years of treatment, with gradual withdrawal after 6 months of seizure freedom.
Main Results:
- Overall remission rates were significantly higher in the 3-year treatment group (71%) compared to the 1-year group (53%).
- Treatment duration significantly impacted outcomes only in children with complex partial seizures (CPS).
Conclusions:
- One year of treatment is sufficient for benign partial epilepsy with rolandic spikes (BECT) and simple partial seizures (SPS).
- A 3-year treatment duration is recommended for complex partial seizures (CPS) in children.
- Accurate seizure classification aids in determining appropriate treatment duration for pediatric idiopathic epilepsy.
Purpose:
The main purpose of this prospective study was to analyze whether 1 year of treatment was as effective as 3 years with respect to remission rate in children with idiopathic epilepsy.
Methods:
Treatment for epileptic seizures was started in 207 children aged 2-16 years. They were randomized to treatment for 1 or 3 years. At the end of the predetermined treatment period, 161 children had been seizure-free for 6 months and the treatment could be gradually withdrawn.
Results:
The overall remission rate in our group of patients was significantly higher (71%) in the group treated for 3 years than in the group treated for 1 year (53%). However, comparison of remission rates between patients with different seizure types showed statistically significant differences in outcome depending on duration of treatment only in children with complex partial seizures (CPS).
Conclusions:
Our results show that 1 year of treatment can be recommended in children with benign partial epilepsy with rolandic spikes (BECT) and in children with simple partial seizures (SPS) but is clearly insufficient in children with CPS. A proper seizure classification is one important tool, although not sufficient, in offering recommendations concerning the duration of treatment in children with idiopathic epilepsy.